Publicis, FR0000130577

Pernod Ricard stock holds focus as fiscal 2025 results frame the outlook

Published on 07/23/2026 at 21:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pernod Ricard stock stays centered on fiscal 2025 earnings, with revenue, profit, and margin figures still guiding the debate around the French spirits group.

Photorealistic open loft agency office with designers at Mac computers and mood boards on glass walls
Publicis FR0000130577 creative agency loft office with designers at computers and moodboards, Illustration mit AI erstellt.

Pernod Ricard (FR0000130577) remains a report-driven stock after its fiscal 2025 numbers set the frame for investors watching revenue, profit, and margin trends into the next trading session. The company reported fiscal 2025 sales of EUR 10.96 billion, while organic net sales fell 3% and recurring operating profit declined 7% on an organic basis, according to its investor materials on Pernod Ricard investor relations.

Sales down 3% in fiscal 2025

The fiscal 2025 sales line of EUR 10.96 billion gives the clearest current anchor for Pernod Ricard stock, because it comes with an organic net sales decline of 3% against the prior year. That comparison matters more than the headline total alone, since it shows how the group performed after currency and portfolio effects were stripped out.

Recurring operating profit fell 7% organically in fiscal 2025, which is a sharper decline than the sales line and points to pressure below revenue. The margin effect is visible in the gap between top-line sales and profit movement, and that is the key number for anyone tracking whether the group can stabilize earnings momentum.

Profit fell 7%

Pernod Ricard also pointed to free cash flow of EUR 1.1 billion in fiscal 2025, giving investors a second hard metric to offset the softer operating trend. Net debt stood at EUR 11.3 billion at 30 June 2025, a level that keeps balance-sheet discipline part of the story alongside profitability.

The combination of EUR 1.1 billion in free cash flow and EUR 11.3 billion in net debt means the market can judge both cash generation and leverage from the same annual update. For Pernod Ricard stock, that pairing is more useful than any broad sector label because it links earnings resilience to financial flexibility.

Cash flow and debt

Read deeper

Pernod Ricard fiscal 2025 numbers at a glance

The latest annual investor material puts sales, profit, cash flow, and debt in one place for a fast read on the French spirits group.

Ballantine

Ballantine remains one of the group’s most visible Scotch whisky brands, and its scale matters because Pernod Ricard’s fiscal 2025 figures depend heavily on premium spirits demand across markets and price tiers. The broader portfolio context is important when sales soften, because branded mix and regional performance can move profit faster than headline revenue.

That is why the fiscal 2025 set is more revealing than a single quarterly snapshot: it combines sales of EUR 10.96 billion, an organic sales decline of 3%, and recurring operating profit down 7%. The investor takeaway is straightforward: revenue, margin, and cash generation are now the numbers to watch together.

Closing price context

Market pricing was not available in the search results, so the clearest live reference remains the fiscal 2025 investor update and its dated operating metrics. For Pernod Ricard stock, the most recent hard data still points to sales of EUR 10.96 billion, free cash flow of EUR 1.1 billion, and net debt of EUR 11.3 billion as the main anchors for valuation work.

Pernod Ricard stock facts

  • Company: Pernod Ricard S.A.
  • ISIN: FR0000130577
  • Ticker: Euronext Paris: RI
  • Trading venue: Euronext Paris
  • Sector / Industry: Consumer Staples / Distillers & Vintners
  • Index membership: CAC 40
  • Market capitalization: not provided in the available sources
  • Next earnings date: not officially scheduled in the available sources

Pernod Ricard stock social search

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | FR0000130577 | PUBLICIS | boerse | 69856135 | bgmi